Form D · Biotechnology

BioCardia, Inc.

San Carlos, CA · CIK 0000925741

Offering snapshot reported Jan 7, 2019 · SEC filing

Reported sold
$4M
Offering amount: $4M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 24, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 7, 2019Initial$4,000,000No comparison3SEC filing
Nov 4, 2016Initial$35,873,625No comparison192SEC filing
Dec 16, 2009Initial$6,215,250No comparison74SEC filing
Oct 13, 2009Initial$3,041,260No comparison43SEC filing
Sep 12, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$200K
Finders' fees
$0
Form D file number
021-329834
Fee paid as part of an exclusivity provision

Source: Form D, filed Jan 7, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard T. Allen Executive
Peter Altman Director, Executive
Andrew Brooks Director, Executive
Eric Duckers Executive
Fernando L. Fernandez Director
Richard Krasno Director
Mikhail Kvitnitsky Director, Executive
Joseph Loggia Director
David Mcclung Executive
David Mc Clung Executive
Thomas Morgan Director
Jay M. Moyes Director
Phil Pesta Executive
Richard C. Pfenniger Director
Richard C. Pfenniger, Jr Director
Thomas Quertermous Director
Ronald Richards Director
Derrick Romine Executive
Steven Rubin Director
Simon Stertzer Director
Allan R. Tessler Director
Subbarao Uppaluri Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
125 Shoreway Road Suite B
San Carlos, CA, 94070